Editorial · 31 May 2025
Research articlePublished 26 Apr 2017
Hyperglycemia and obesity related with intestinal neoplasia. Survey in an oncology centre.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: One of the most common causes of malignant neoplams is colorectal cancer. This pathology may generate severe illness and complications leading to death. Metabolic dysfunction, including obesity and hyperglycemia, has increased exponentially and previous studies have suggested an association between those risk factors and a greater risk of colorectal cancer. Aim: To assess the prevalence and the role of metabolic pathology in patients with intestinal cancer. Methods: A descriptive and retrospective study conducted at a Cancer Reference Center in Sao Paulo of patients diagnosed with intestinal cancers. During the first consult, the fasting blood glucose and body mass index were verified. The Student T-test was used. The rejection standard of the null hypothesis was set at 0.05 or 5% (α ≤ 0.05). Results: Our study analyzed 105 patients, of which 60-69 year olds were the more prevalent age group. Of those studied, 50% of the patients were found to be overweight and obese and 47.6% were found to be hyperglycemic. The prevalent weight group of patients were those classified as overweight being between 25 and 29 kg/m2 showing an incidence of 47.4% of rectal cancer and 52.4% of colon cancer. The hyperglycemic patient group showed a prevalence of 28% with rectal cancer and 72% with colon cancer. Those showing rectal cancer consisted of 57,2% men and 28.5% women. Those showing colon cancer demonstrated a prevalence of 41.6% of men and 5.5% women. However, those patients within the hyperglycemic group had no prior diagnosis of T2DM and were unaware of their condition. Conclusion: Our study emphasizes the importance of metabolic disorders and the necessity of effective preventive health measures in attempt to prevent the development of severe pathology with high rate of mortality.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Medical Oncology and Therapeutics.
Opinion · 31 May 2025
The Importance of Early-Phase Clinical Trials in Developing New Cancer Therapies
Short communication · 31 May 2025
Understanding Cancer Drug Resistance: Mechanisms and Solutions
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medical Oncology and Therapeutics
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Beatriz Dal Santo Francisco Bonamichi”
- BylineArticles whose byline prints “Carla Andressa Rodrigues Dias”
- BylineArticles whose byline prints “Patricia Massae Marubayashi”
- BylineArticles whose byline prints “Rafael Bonamichi dos Santos”
- BylineArticles whose byline prints “Hezio Jadir Fernandes Junior”
- BylineArticles whose byline prints “Joao Eduardo Nunes Salles”
